biote Corp. (BTMD) Form 10-Q Quarterly Reports
biote Corp. (BTMD) is a publicly traded company on the Nasdaq, categorized under SIC 2833 (Medicinal Chemicals & Botanical Products). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BTMD
CIK: 1819253
Exchange: Nasdaq
SIC 2833: Medicinal Chemicals & Botanical Products
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerJonathan Stanley
Audit LocationDallas, Texas, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-09-18 | — | SCHEDULE 13G/A Filing | 0001820959-26-000001 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-09-01 | — | SCHEDULE 13G/A Filing | 0001493152-26-041060 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-28 | — | SCHEDULE 13G Filing | 0001493152-26-040561 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | 4 Filing | 0001314575-26-000007 | View SEC Doc Filr Page |
| 10-Q | 2026-08-07 | 2026-06-30 | 10-Q | 0001193125-26-340364 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001193125-26-335200 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-27 | — | SCHEDULE 13G/A Filing | 0002012383-26-002270 | View SEC Doc Filr Page |
| 8-K/A | 2026-06-17 | 2026-06-12 | 8-K/A | 0001193125-26-274137 | View SEC Doc Filr Page |
| 4 | 2026-06-16 | 2026-06-12 | PRIMARY DOCUMENT | 0002005188-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-08 | PRIMARY DOCUMENT | 0001707443-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-08 | PRIMARY DOCUMENT | 0001314575-26-000004 | View SEC Doc Filr Page |
| 8-K | 2026-06-02 | 2026-05-27 | 8-K | 0001193125-26-253858 | View SEC Doc Filr Page |
| 8-K | 2026-05-18 | 2026-05-12 | 8-K | 0001193125-26-229013 | View SEC Doc Filr Page |
| 4 | 2026-05-14 | 2026-05-12 | 4 Filing | 0001259062-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-13 | 2026-05-12 | PRIMARY DOCUMENT | 0001838995-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-05-13 | 2026-05-12 | PRIMARY DOCUMENT | 0001931328-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-13 | 2026-05-12 | PRIMARY DOCUMENT | 0001931319-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-13 | 2026-05-12 | PRIMARY DOCUMENT | 0001314575-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-13 | 2026-05-12 | PRIMARY DOCUMENT | 0001773204-26-000002 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-13 | — | SCHEDULE 13G/A Filing | 0000921895-26-001270 | View SEC Doc Filr Page |
| 10-Q | 2026-05-11 | 2026-03-31 | 10-Q | 0001193125-26-216780 | View SEC Doc Filr Page |
| 8-K | 2026-05-06 | 2026-05-06 | 8-K | 0001193125-26-208965 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-05-01 | 4 Filing | 0002125693-26-000005 | View SEC Doc Filr Page |
| 3 | 2026-05-04 | 2026-04-27 | 3 Filing | 0002125693-26-000004 | View SEC Doc Filr Page |
| S-8 | 2026-04-14 | — | S-8 | 0001193125-26-155037 | View SEC Doc Filr Page |